Video

More Research is Needed to Prevent Late-Stage Diagnosis of Ovarian Cancer

A gynecologic-oncology clinical nurse specialist and one of this year’s CURE Ovarian Cancer Heroes discussed the lack of resources for patients with ovarian cancer and the need for more research.

Of the many challenges facing patients with ovarian cancer, one of the biggest is late-stage or delayed diagnosis due to the disease’s subtle signs and symptoms, according to Paula Anastasia RN, MN, AOCN.

At CURE’s Ovarian Cancer Heroes event, Anastasia — one of this year’s winners who works at the David Geffen School of Medicine at UCLA – discussed some of the resources that are lacking for patients with ovarian cancer.

“It is unfortunately one of the most fatal (forms of cancer) because it is diagnosed in the late stages,” said Anastasia, who has been a gynecologic-oncology clinical nurse specialist for more than 25 years. “The reason is there is not enough information on the signs and symptoms.”

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Waldenstrom macroglobulinemia is often slow growing, with high survival but lower quality of life over time, explained researcher Alisha Kimble.
Image of woman.
Image of two doctors and text.
Combining JNJ-1900 with Keytruda may improve distant control of lung cancer, explained by Dr. Jared Weiss.
image of serzan.
Dr. Breelyn Wilky explains that personalized treatments are helping improve outcomes for patients with gastrointestinal stromal tumors.
Image of two doctors with text.
Image of doctors with text.
Treatment with zanzalintinib plus Opdivo and Opdualag is an option worth exploring in patients with previously untreated clear cell renal cell carcinoma
Image of two doctors and text.
Related Content